Western blot analysis on breast cancer cells treated with Averufanin reveled increase in phosphorylation of p53 (Fig. 7A) and in cleavage of PARP (Fig. 7B) compared to DMSO controls which supports induction of apoptosis. Here, TP53 is linked to breast cancer.